Lucas E. Montarce, Executive Vice President and CFO of Eli Lilly & Co (NYSE:LLY), filed a Form 4 on November 3, 2026, disclosing the vesting of 1,610 restricted stock units and a related tax-withholding disposition of shares on November 1, 2026.

Key Highlights

  • RSU vesting: 1,610 restricted stock units converted to common stock on November 1, 2026, at a price of $0, coded as transaction type M.
  • Shares withheld for taxes: 677.593 shares were disposed of (transaction code F) at $1,417.54 per share on the same date.
  • Resulting ownership: Following both transactions, Montarce directly held 17,190.88 shares of Eli Lilly common stock.
  • RSU balance: The derivative security (restricted stock unit) balance stands at 0 following the vesting, per the filing.
  • Unit definition: According to the filing, "each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."

Montarce RSU Vesting and Tax Withholding Details - November 2026

According to the Form 4 filed with the SEC on November 3, 2026, Lucas E. Montarce, who serves as EVP and CFO of Eli Lilly & Co (NYSE:LLY), reported two transactions in the company's common stock, both dated November 1, 2026. The first was the vesting of 1,610 restricted stock units (transaction code M), which converted into an equal number of shares of common stock at a price of $0 per unit, bringing his directly held share total to 17,868.473 shares at that point.

Immediately following the vesting, the filing discloses a disposition of 677.593 shares (transaction code F) at a price of $1,417.54 per share. Transaction code F, as defined in SEC instructions, reflects shares withheld by the issuer to satisfy a tax withholding obligation. After this disposition, Montarce's directly held beneficial ownership of Eli Lilly common stock stood at 17,190.88 shares, according to the filing.

The filing was signed by Jonathan Groff on behalf of Lucas E. Montarce, pursuant to an authorization on file. The form indicates it was filed by one reporting person, with no amendment to a prior filing noted. All ownership reported is direct.

What Was Disclosed

The filing reports the vesting of 1,610 restricted stock units and the withholding of 677.593 shares at $1,417.54 each to cover taxes, leaving Montarce with a direct beneficial ownership of 17,190.88 Eli Lilly common shares as of November 1, 2026.